The Â鶹ÊÓƵ aims to maximise the impact of its through Knowledge Exchange and Commercialisation (KEC) in order to translate research into action for social and economic benefit. A key part of our KEC strategy is to partner with industry, particularly biotech and pharma companies, to translate our research and support the bioeconomy.
We benefit from being co-located with around on the , and collaborate extensively with these organisations. Babraham Â鶹ÊÓƵ Enterprise Ltd (BIE) supports the commercialisation of the Â鶹ÊÓƵ’s research and access to our core .
Industry priorities:
Commercialisation of Â鶹ÊÓƵ research and access to is the responsibility of the Commercialisation Manager.